[1] |
BERRÍOS-TORRES S I, UMSCHEID C A, BRATZLER D W, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017[J]. JAMA Surg,2017,152(8):784-791. doi: 10.1001/jamasurg.2017.0904 |
[2] |
巴特利特, 奥威特, 等. ABX指南: 感染性疾病的诊断与治疗[M]. 北京: 科学技术文献出版社, 2012 |
[3] |
葛瑛. 《耐甲氧西林金黄色葡萄球菌感染防治专家共识》解读[J]. 中国临床医生, 2014, 42(3):11-12. |
[4] |
万古霉素临床应用中国专家共识(2011版)[J]. 中国新药与临床杂志, 2011, 30(8): 561-573 |
[5] |
BRATZLER D W, DELLINGER E P, OLSEN K M, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery[J]. Am J Health Syst Pharm,2013,70(3):195-283. doi: 10.2146/ajhp120568 |
[6] |
RYBAK M J, LE J, LODISE T P, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists[J]. Am J Health Syst Pharm,2020,77(11):835-864. doi: 10.1093/ajhp/zxaa036 |
[7] |
何志超, 伍俊妍, 邱凯锋. 万古霉素个体化给药临床药师指引[J]. 今日药学, 2015, 25(2):78-82. |
[8] |
ÁLVAREZ R, LÓPEZ CORTÉS L E, MOLINA J, et al. Optimizing the clinical use of vancomycin[J]. Antimicrob Agents Chemother,2016,60(5):2601-2609. doi: 10.1128/AAC.03147-14 |
[9] |
唐莲, 严晓薇, 彭秋菊, 等. 肾功能亢进患者万古霉素血药浓度监测与临床疗效分析[J]. 中国医院药学杂志, 2018, 38(15):1629-1632. |
[10] |
王凌, 眭玉霞. 渗透性治疗对神经危重症患者万古霉素血药浓度的影响[J]. 中国执业药师, 2016, 13(010):3-5. |
[11] |
HOBBS A L, SHEA K M, ROBERTS K M, et al. Implications of augmented renal clearance on drug dosing in critically ill patients: a focus on antibiotics[J]. Pharmacotherapy,2015,35(11):1063-1075. doi: 10.1002/phar.1653 |
[12] |
HEALY D P, SAHAI J V, FULLER S H, et al. Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions[J]. Antimicrob Agents Chemother,1990,34(4):550-554. doi: 10.1128/AAC.34.4.550 |
[13] |
广东省药学会. 临床药师术后疼痛管理指引[J]. 今日药学, 2019, 29(4):217-227. |
[14] |
European Association for the Study of the Liver. Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol, 2019, 70(6): 1222-1261. |
[15] |
周红玲, 刘年开, 丁楠. 万古霉素致严重肝损害1例[J]. 中国执业药师, 2012, 9(10):40-41. |
[16] |
梁瑜, 孟真, 仓怀芹, 等. 注射用盐酸万古霉素致急性药物性肝损伤1例分析[J/OL]. 中国药物警戒, (2020-12-28) [2021-05-12]. http://kns.cnki.net/kcms/detail/11.5219.R.20201228.1229.002.html |
[17] |
SERRANTI D, MONTAGNANI C, INDOLFI G, et al. Antibiotic induced liver injury: what about children? J Chemother,2013,25(5):255-272. doi: 10.1179/1973947813Y.0000000090 |
[18] |
CADLE R M, MANSOURI M D, DAROUICHE R O. Vancomycin-induced elevation of liver enzyme levels[J]. Ann Pharmacother,2006,40(6):1186-1189. doi: 10.1345/aph.1G668 |